Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Martin A, Katzman"'
Autor:
Pratap Chokka, Ash Bender, Stefan Brennan, Ghalib Ahmed, Marc Corbière, David J. A. Dozois, Jeff Habert, John Harrison, Martin A. Katzman, Roger S. McIntyre, Yang S. Liu, Karen Nieuwenhuijsen, Carolyn S. Dewa
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
Major depressive disorder (MDD) and other mental health issues pose a substantial burden on the workforce. Approximately half a million Canadians will not be at work in any week because of a mental health disorder, and more than twice that number wil
Externí odkaz:
https://doaj.org/article/ab128902cce445cf98b04324cc82f6b6
Autor:
Gregory W. Mattingly, Hongye Ren, Michael Cronquist Christensen, Martin A. Katzman, Mircea Polosan, Kenneth Simonsen, Lene Hammer-Helmich
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
BackgroundRandomized controlled clinical trials have shown vortioxetine to be efficacious and well tolerated for the treatment of major depressive disorder (MDD). The Real-Life Effectiveness of Vortioxetine in Depression (RELIEVE) study was undertake
Externí odkaz:
https://doaj.org/article/67c0f309618c438d9c8f7e9bba09cf9b
Autor:
Daniel Di Matteo, Kathryn Fotinos, Sachinthya Lokuge, Geneva Mason, Tia Sternat, Martin A Katzman, Jonathan Rose
Publikováno v:
Journal of Medical Internet Research, Vol 23, Iss 8, p e28918 (2021)
BackgroundThe lack of access to mental health care could be addressed, in part, through the development of automated screening technologies for detecting the most common mental health disorders without the direct involvement of clinicians. Objective
Externí odkaz:
https://doaj.org/article/2d75edc79dd6423a97768d101ba915bc
Publikováno v:
Journal of Pharmacy & Pharmaceutical Sciences, Vol 22, Iss 1 (2020)
Paliperidone palmitate is a second generation antipsychotic, approved for the treatment of schizophrenia in the form of the long-acting injectable (LAI) products INVEGA SUSTENNA® (once monthly injection) and INVEGA TRINZA® (once every 3 months inje
Externí odkaz:
https://doaj.org/article/7f771ba915784089840b7e6f5265a6a2
Autor:
Martin A. Katzman, Matthew P. Katzman
Publikováno v:
Brain Sciences, Vol 12, Iss 2, p 150 (2022)
Orexin peptides comprise two neuropeptides, orexin A and orexin B, that bind two G-protein coupled receptors (GPCRs), orexin receptor 1 (OXR1) and orexin receptor 2 (OXR2). Although cell bodies that produce orexin peptides are localized in a small ar
Externí odkaz:
https://doaj.org/article/cd295364dddc4d268504b1dc5ded6e5d
Autor:
Martin A, Katzman, François, Therrien, Erin M, MacKenzie, Fan, Wang, Anne, de Jong-Laird, Matthieu, Boucher
Publikováno v:
Journal of Affective Disorders. 316:201-208
Major depressive disorder (MDD) is a clinically heterogenous condition and its treatment should be individualized according to the presence of particular symptom clusters. The aim of this pooled analysis was to investigate the effects of adjunctive b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d523801fb988e2ac79a37d27190b5a77
https://doi.org/10.1016/j.jad.2022.08.021
https://doi.org/10.1016/j.jad.2022.08.021
Publikováno v:
Journal of Evidence-Based Integrative Medicine, Vol 24 (2019)
North American naturopathic medicine is a distinct form of practice that is woven into the larger fabric of integrative medicine; in a number of US states and Canadian provinces, naturopathic doctors enjoy a wide scope of practice, including the abil
Externí odkaz:
https://doaj.org/article/b8114ac8f90d45a794d4a3bdbcbded40
Autor:
Oloruntoba J. Oluboka, Martin A. Katzman, Jeffrey Habert, Atul Khullar, Margaret A. Oakander, Diane McIntosh, Roger S. McIntyre, Claudio N. Soares, Raymond W. Lam, Larry J. Klassen, Robert Tanguay
Publikováno v:
CNS Spectrums. 28:145-156
Major depressive disorder (MDD) is the leading cause of disability worldwide. Patients with MDD have high rates of comorbidity with mental and physical conditions, one of which is chronic pain. Chronic pain conditions themselves are also associated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed82cc1ff611ad7661455294a0757ac8
https://doi.org/10.1017/s1092852922000128
https://doi.org/10.1017/s1092852922000128
Autor:
Jennifer Swainson, Larry J. Klassen, Stefan Brennan, Pratap Chokka, Martin A. Katzman, Robert L. Tanguay, Atul Khullar
Publikováno v:
CNS Drugs. 36:239-251
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4117372c9c0688b3f86131f9ce70079f
https://doi.org/10.1007/s40263-022-00897-2
https://doi.org/10.1007/s40263-022-00897-2
Autor:
Borwin Bandelow, Christer Allgulander, David S. Baldwin, Daniel Lucas da Conceição Costa, Damiaan Denys, Nesrin Dilbaz, Katharina Domschke, Eric Hollander, Siegfried Kasper, Hans-Jürgen Möller, Elias Eriksson, Naomi A. Fineberg, Josef Hättenschwiler, Hisanobu Kaiya, Tatiana Karavaeva, Martin A. Katzman, Yong-Ku Kim, Takeshi Inoue, Leslie Lim, Vasilios Masdrakis, José M. Menchón, Euripedes C. Miguel, Antônio E. Nardi, Stefano Pallanti, Giampaolo Perna, Dan Rujescu, Vladan Starcevic, Dan J. Stein, Shih-Jen Tsai, Michael Van Ameringen, Anna Vasileva, Zhen Wang, Joseph Zohar
Publikováno v:
world journal of biological psychiatry. Taylor and Francis Ltd.
Aim: This is the third version of the guideline of the World Federation of Societies of Biological Psychiatry (WFSBP) Task Force for the Pharmacological Treatment of Anxiety, Obsessive–Compulsive and Posttraumatic Stress Disorders which was publish
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::466132d6b928628a86fbf6649cc81c83
